Literature DB >> 8307480

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

P Michieletti1, I R Wanless, A Katz, P J Scheuer, S J Yeaman, M F Bassendine, J M Palmer, E J Heathcote.   

Abstract

This study reports on a group of 20 patients with an initial diagnosis of primary biliary cirrhosis (PBC) whose serum tested negative for antimitochondrial antibodies by immunofluorescence. All had a clinical history compatible with primary biliary cirrhosis, and results of biochemical, histological, and radiological investigations were consistent with this diagnosis despite the absence of antimitochondrial antibodies by immunofluorescence. For comparison, these patients were matched for sex and serum bilirubin with 20 antimitochondrial antibody positive (> 1:160) and histologically confirmed primary biliary cirrhosis patients who served as controls. Serum samples from both groups were retested blindly for antimitochondrial antibodies using immunoblotting and for antibodies to the major M2 mitochondrial autoantigens by enzyme linked immunosorbent assay (ELISA). Three antimitochondrial antibody immunofluorescence negative patients had antimitochondrial antibodies by immunoblotting and ELISA; the remaining 17 patients were confirmed negative by all methods. The antimitochondrial antibody immunofluorescence positive controls were verified by immunoblotting or ELISA, or both. All 17 patients negative for antimitochondrial antibodies had antinuclear antibodies, often in high titres, compared with 3/17 of the antimitochondrial antibody positive controls (p = 0.0001). Additionally, the antimitochondrial antibody negative group also had significantly higher smooth muscle antibody titres (p = 0.03) and lower serum IgM (p = 0.01) and aspartate aminotransferase (p = 0.03) activities than the antimitochondrial antibody positive controls. Analysis of clinical findings, histological tests, serum bilirubin, alkaline phosphatase, alanine aminotransferase, and IgG, disclosed no significant differences between the two groups. This paper describes a group of patients with the clinical and histological features of PBC but who do not fulfil the usual criteria necessary to make this diagnosis. Because they also have very high titres of antinuclear antibodies, smooth muscle antibodies, and comparatively low IgM and aspartate aminotransferase activities, we believe they are distinct from PBC and have a syndrome of autoimmune cholangitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8307480      PMCID: PMC1374505          DOI: 10.1136/gut.35.2.260

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Serum immunoglobulin concentrations and autoantibody titers in diseases of the liver and biliary tree.

Authors:  A M Ward; G Ellis; D M Goldberg
Journal:  Am J Clin Pathol       Date:  1978-09       Impact factor: 2.493

2.  Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis.

Authors:  J Van de Water; A Cooper; C D Surh; R Coppel; D Danner; A Ansari; R Dickson; M E Gershwin
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

3.  Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors.

Authors:  E H Beutner; M R Sepulveda; E V Barnett
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Idiopathic biliary ductopenia in adults: a report of five cases.

Authors:  E S Zafrani; J M Metreau; C Douvin; D Larrey; R Massari; M Reynes; M Doffoel; J P Benhamou; D Dhumeaux
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

5.  Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart by a new method.

Authors:  C J Stanley; R N Perham
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

6.  Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.

Authors:  J Van de Water; D Fregeau; P Davis; A Ansari; D Danner; P Leung; R Coppel; M E Gershwin
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

7.  [A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)].

Authors:  G Brunner; O Klinge
Journal:  Dtsch Med Wochenschr       Date:  1987-09-18       Impact factor: 0.628

8.  Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis.

Authors:  P S Leung; T Iwayama; T Prindiville; D T Chuang; A A Ansari; R M Wynn; R Dickson; R Coppel; M E Gershwin
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

9.  Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.

Authors:  J Van de Water; A A Ansari; C D Surh; R Coppel; T Roche; H Bonkovsky; M Kaplan; M E Gershwin
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

10.  Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

Authors:  L E Munoz; H C Thomas; P J Scheuer; D Doniach; S Sherlock
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

View more
  36 in total

1.  Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment.

Authors:  M Leuschner; C F Dietrich; T You; C Seidl; J Raedle; G Herrmann; H Ackermann; U Leuschner
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 2.  Primary biliary cirrhosis: new perspectives in diagnosis and treatment.

Authors:  M I Prince; D E Jones
Journal:  Postgrad Med J       Date:  2000-04       Impact factor: 2.401

Review 3.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 4.  Variant forms of autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

5.  Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model.

Authors:  Mikio Zeniya; Fumitoki Watanabe; Toshio Morizane; Minoru Shibata; Shiro Maeyama; Masayoshi Kage; Yasuni Nakanuma; Gotaro Toda
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

6.  Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status.

Authors:  P Invernizzi; P M Battezzati; A Crosignani; P Zermiani; M Bignotto; N Del Papa; M Zuin; M Podda
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

7.  Primary biliary cirrhosis associated with cholangiocarcinoma.

Authors:  N Akisawa; T Maeda; K Tsuda; I Nishimori; M Morita; S Iwasaki; A Tomita; T Saibara; S Onishi; Y Kiyoku; H Enzan
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

Review 8.  Treatment of autoimmune cholangitis.

Authors:  L Mohr; T Heintges; F Hensel; C Niederau; D Häussinger
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

Review 9.  The immunology of primary biliary cirrhosis: the end of the beginning?

Authors:  J M Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

10.  Characterization of M2 antibodies in asymptomatic Chinese population.

Authors:  Xiao-Hua Jiang; Ren-Qian Zhong; Xiao-Yun Fan; Yin Hu; Feng An; Jian-Wen Sun; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.